Skip to main content
Clinical Trials/NCT00549991
NCT00549991
Completed
Not Applicable

Fine Mapping of Hypertension Genes Detected by Admixture Mapping in the FBPP

Case Western Reserve University1 site in 1 country8,687 target enrollmentAugust 1, 2007
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Case Western Reserve University
Enrollment
8687
Locations
1
Primary Endpoint
Genetic variations
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.

Detailed Description

High blood pressure affects nearly one third of all individuals in the United States. It is especially common in African Americans, with more than 40% of African Americans diagnosed with this condition. High blood pressure usually develops earlier in life and is more severe in African Americans than in other racial or ethnic groups. Many factors can cause high blood pressure, including stress, diet, diabetes, kidney disease, or obesity. Previous studies have also shown that genetic variations on two regions of chromosomes 6 and 21 may predispose some people to develop high blood pressure. Admixture mapping is a type of genetic analysis that aims to identify disease-causing genetic variations across different populations of people. Using admixture mapping, this study will examine previously collected genetic samples from African American participants in the Family Blood Pressure Program (FBPP) study and from African American, Mexican American, Nigerian, and Jamaican participants enrolled in other clinical studies. Study researchers will analyze the samples to identify and characterize genetic variations that are associated with an increased risk of high blood pressure in the African American population, as well as other racial and ethnic groups.

Registry
clinicaltrials.gov
Start Date
August 1, 2007
End Date
June 1, 2012
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participated in the FBPP study (African American \[800 people with high blood pressure and 800 control group participants\] and Mexican American participants)
  • Participated in the American Family Study (African American participants)
  • Participated in the Phenotyping Study (African American, Nigerian, and Jamaican participants)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Genetic variations

Time Frame: Measured through admixture mapping genetic analysis

Study Sites (1)

Loading locations...

Similar Trials